BiotechTube
Home/Fennec Pharmaceuticals/Pierre S. Sayad
PS

Pierre S. Sayad

Chief Medical Officer

Fennec Pharmaceuticals

Therapeutic Areas

OncologyOtology

Fennec Pharmaceuticals Pipeline

DrugIndicationPhase
Pedmark (Sodium Thiosulfate)Prevention of Cisplatin-Induced Ototoxicity in pediatric localized solid tumorsApproved
Sodium ThiosulfatePrevention of CIO in newly diagnosed hepatoblastoma (Compassionate Use)N/A

Leadership Team at Fennec Pharmaceuticals

JH
Jeff Hackman
Chief Executive Officer and Director
RA
Robert Andrade
Chief Financial Officer
TE
Terry Evans
Chief Commercial Officer
View full Fennec Pharmaceuticals profile